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ABSTRACT 
Background Mild cognitive impairment (MCI) can be regarded as a risk for 
developing dementia. Early diagnosis of MCI enables timely medical and non-medical 
intervention for patients as well as social support networks for caregivers. This is 
essential as the prevalence of dementia is increasing worldwide. 
Objective The Visual Cognitive Assessment Tool (VCA T) may be comparable to 
MoCA and MMSE in detecting MCI, without the need for translation into other 
languages or adaptations. 
Method The VCAT, MoCA and MMSE were administered to participants from the 
Falls clinic of University Malaya. The sensitivity and specificity, area under the curve 
(AUC) as well as post-hoc analysis was assessed for the detection of MCI and 
dementia. 
Results VCA T was comparable to MoCA and MMSE in a sample of 96 participants. 
The sample comprised of 50 Healthy Fallers and 46 Cognitively Impaired Subjects. 
AUC of VCAT for detection of cognitive impairment was 88.3(95% CI 81.3 to 95.3). 
The sensitivity and specificity of VCA T in diagnosing cognitive impairment was 
80% and 82% respectively. VCAT had better sensitivity than MMSE, and better 
specificity than MoCA. Post-hoc analysis showed that VCAT offers better 
differentiation for normal controls versus MCI in comparison to MoCA and MMSE. 
Mean time to completion ofVCAT was 13.0 ± 5.7 min. 
Conclusions The VCA T has good sensitivity and specificity for diagnosing cognitive 
impairment. It may also offer better differentiation for normal controls versus MCI 
compared to MoCA and MMSE. It also offers the advantage of being visual based, 
thus avoiding the need for adaptations or translations into other languages. 
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CHAPTERl: INTRODUCTION 
Dementia is a clinical syndrome linked to neurodegeneration and characterized by 
progressive deterioration in cognitive ability and capacity for independent living 
(Prince M, Bryce R, 2013). According to DSM-IV, the criteria for dementia is the 
development of multiple cognitive deficits manifested by both memory impairment 
and one or more of the following cognitive disturbances: aphasia, apraxia, agnosia 
or a disturbance in executive functioning. The cognitive defects in memory 
impairment and cognitive disturbances are associated with impairment in social 
or occupational functioning and is required to represent a measurable decline from 
the previous level of functioning. The disturbance also should not occur during 
an acute illness or the presence of medical conditions linked to delirium and 
disturbances in higher mental function. Mild cognitive impairment (MCI) 
represents an intermediate state of cognitive function between the changes seen 
in aging and those fulfilling the criteria for dementia and Alzheimer's disease 
(Petersen RC, Smith GE, 1999). 
MCI is classified into two subtypes: amnestic and non-amnestic (Petersen RC, 2004). 
Amnestic mild cognitive impairment is clinically significant memory impairment 
that does not meet the criteria for dementia. Non-amnestic mild cognitive 
impairment is characterized by a subtle decline in functions not related to memory, 
affecting attention, use of language, or visuospatial skills. The non-amnestic type of 
mild cognitive impairment is probably less common than the amnestic type and 
may be the forerunner of dementi as that are not related to Alzheimer's disease, 
such as frontotemporal lobar degeneration or dementia with Lewy bodies (Molano J, 
Boeve B, 2010). In clinical trials involving patients with amnestic MCI, more 
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than 90% of those with progression to dementia have clinical signs of Alzheimer's 
disease (Petersen RC, Thomas RG, 2005). The estimated prevalence of MCI 10 
population-based studies range from 10 to 20% in persons older than 65 years 
of age (Busse A, Hensel A, 2006). 
There is a growing need to diagnose the early stages of cognitive impairment as the 
prevalence of dementia is increasing worldwide (Brookmeyer R, GrayS, 1998). 
An early diagnosis of dementia is essential for establishing effective medical 
interventions and social support networks. These patients would need regular 
clinical follow-ups, as well as pharmacological and lifestyle interventions to 
prevent the progression towards dementia (Winblad B, et al 2004). 
Neuropsychometric assessments are presumed to be the best method to screen 
individuals in most developing countries (Chaves et al 1999). At the outset, the 
lack of standardization of screening tools has to be recognized as a major issue in 
the estimation of the true burden (Rodriguez et al 2008). Standardization might 
not be readi ly achieved because of diversity in language, culture, and levels 
of literacy. In certain communities, more than 80% of older people do not read 
or write (Hall KS et al, 1996). The mini mental state examination (MMSE) has 
been translated into many languages, but its use might be limited even as an initial 
screening tool. In a study done by Scazufca et al in 2009, education, age, sex and 
income influenced MMSE scores, independently of dementia cases. 
Similarly in Asia, a systematic review of the cognitive assessment tools used 
found that the MMSE is also influenced by age, education levels as well as 
cultural and ethnic differences (Rosli et al, 20 15). 
The development of tools with no linguistic and educational biases are urgently 
needed to address the rapid increase in persons with dementia in developing 
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countries. The Visual Cognitive Assessment Tool (VCA T) is a brief visual based 
assessment tool that may be more suitable for multicultural and multilingual 
societies around the world (Kandiah Net al, 2015). It is designed to screen and 
detect for early cognitive impairment in the older population by assessing five 
different cognitive domains- memory, visuospatial executive function, language 
and attention. It offers the advantage of avoiding the need to translate or adapt to 
other languages or dialects as long as the administrator and participant speak 
the same language (Kandiah, N, et a12015). 
Standardized cognitive batteries will facilitate information flow through the health 
system. The cognitive battery needs to be simple enough to be adopted into the clinical 
setting. Minimal or no training should be needed to use it as a screening tooL Thus, the 
same tool can be easily used to monitor patient progress and improvement. Clinicians 
would use cognitive evaluation to chart progress as patients with dementia transition 
between the different bealthcare settings for diagnosis, treatment, and management 
(Kua, J, 2004). 
The objective of this study is to evaluate the validity and psychometric properties 
ofVCAT as an assessment tool for the detection of mild cognitive impairment (MCI) 
as well as dementia in a multi-racial urban area of Malaysia, University of Malaya 
in comparison with the Montreal Cognitive Assessment (MoCA) and MMSE. 
Our hypotheses therefore include: 
1. The VCA T would be more practical in a multilingual and multicultural 
society as it removes the need for translations with consequent loss of 
original intent oft~sts. 
u. The VCA T will have sensitivity and specificity comparable to the MoCA 
for the detection of mild cognitive impairment. Compared to the MoCA, 
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the VCA T can be administered without the need for translation and >90% 
of subjects will be able to complete the test. 
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CHAPTER 2: LITERATURE REVIEW 
2.1 Definition ofDementia 
Dementia is a syndrome (either of a chronic or progressive nature), in which there is 
deterioration in cognitive function beyond what might be expected from normal 
ageing. It affects memory, thinking, orientation, comprehension, calculation, 
learning capacity, language, and judgement. Consciousness is not affected. 
The impairment in cognitive function is commonly accompanied, and occasionally 
preceded, by deterioration in emotional control, social behaviour, or motivation 
(World Health Organization, 2017). 
Dementia impacts not only the patient' s quality of life, but also for their caregivers 
as it is typically associated with particularly intense needs for care, exceeding the 
demands associated with other conditions (World Alzheimer Report 2015). There is 
often a lack of awareness and understanding of dementia, resulting in stigmatization 
and barriers to earlier diagnosis and better care (World Health Organization, 2017). 
2.2 Epidemiology of Dementia 
Alzheimer's disease (AD) is the most common form of dementia in older persons 
(van der Flier WM et al, 2005). The other major dementia syndromes include 
dementia with Lewy bodies, frontotemporal dementia, vascular dementia and 
Parkinson 's disease with dementia. Currently, the world's older population 
comprises of nearly 900million people. There are an estimated 48 million people 
worldwide who are living with dementia in 2015. This number will almost 
double every 20 years to 74.7 million in 2030 to 131.5 million in 2050 (World 
Alzheimer Report 2015). For South-East Asia, the predicted growth rate for the 
number of people with dementia will be 68% (World Alzheimer Report 2015). 
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The incidence of dementia is also increasing exponentially with increasing age. There 
are an estimated 9.9 miJlion new cases reported yearly worldwide, implying one new 
case every 3.2 seconds. Out of these new cases, 49 % will be in Asia, 25% in Europe, 
18% in the Americas and 8% in Africa (World Alzheimer Report 2015). 
2.3 Diagnosing Dementia 
Early diagnosis of dementia remains a challenge for medical practitioners. Freud B 
in 2006 and Lin JS in 2013 have found that health care professionals commonly 
miss the diagnosis of cognitive impairment or dementia; the prevalence of missed 
diagnosis ranges from 25% to 90%. Primary care physicians may not recognize 
cognitive impairment until the moderate to severe stage. Most patients with dementia 
do not present with a complaint of memory loss; rather in most cases it is the spouse 
or other informant who will bring up the problem to the physician's attention. 
Informant reported memory loss is a much better predictor of the current presence 
and future development of dementia, whereas self -reported memory loss does not 
appear to correlate with the subsequent development of dementia (Carr DB, Gray S, 
2000). 
Screening tests are quick and useful tools to assess the cognitive condition of patients 
(Ashford JW, Borson S, 2006). The MMSE is the most widely used screening test 
for dementia, followed by MoCA (Tsoi KK, Chan JY et al, 2015). 
The MMSE was developed as a screenmg test to quantitatively assess the severity 
of cognitive impairment and to document cognitive changes that occur over time. 
It has various questions with a maximum score of 30 points, and can usually be 
administered within 5-10 minutes. Tarnbaugh and Mcintyre (1992) reviewed the 
strengths and weaknesses of the MMSE. They concluded that the MMSE has 
moderate to high levels of reliability, and the criterion validity measures show 
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moderate to high sensitivity levels for moderate-to- severe dementia. Of the 
demographic factors, age and education level exert the greatest effect. The MMSE, 
however, is not without its shortcomings. One of the most frequently cited was its 
lack of sensitivity to mild cognitive impairment and its failure to adequately 
discriminate patients with mild AD from normal patients. It is also highly verbal, 
lacking sufficient items to adequately measure visuospatial and/or constructional 
praxis. Items designed to measure language functions tend to be overly simplistic 
and insensitive to mild linguistic deficits, hence increasing the number of false 
negative errors (Tombaugh TN et al, 2002). 
The Montreal Cognitive Assessment (MoCA) has since been developed to screen 
for patients who have mild cognitive impairment and who usually perform m the 
normal range of the MMSE. It is a one-page 30 point test that takes around 
1 0 minutes to complete (Nasreddinne et al, 2005). It showed high test-retest 
reliability and good internal consistency. Its sensitivity and specificity in detecting 
mild cognitive impairment was 90% and 87% respectively. The MMSE in contrast, 
only had a sensitivity of 18% for the detection of MCI (Nasreddinne et al, 2005). 
Rosetti and Lacritz et al produced normative and descriptive data for MoCA m a 
population of2, 653 ethically diverse subjects as part of a population based study 
for cardiovascular diseases. They found that the MoCA scores were significantly 
correlated with age, was more strongly associated with education and had no relation 
to gender. They summarized that the MoCA scores needed to be interpreted with 
caution in multicultural societies, and especially those with lower levels of education 
(Rosetti H C et al, 20 11 ). 
A few cognitive assessment tests such as the Eurotest, Phototest and Memory 
Alteration test have been useful in demonstrating cognitive impairment in those 
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without a formal education (Camero-Pardo C et al, 2006; Camero-Pardo C et al 2011· 
' ' 
Rami L et al, 201 0). These tests have yet to be evaluated or validated in Malaysia. 
The Visual Cognitive Assessment Tool (VCA T) is a brief and visual based 
assessment tool that may be more suitable for multilingual and multicultural societies 
such as Malaysia. It offers the advantage of bypassing the need for translations or 
adaptations into other languages or dialects (Nagendran et al, 2015). It was developed 
using a 5 -step process. Based on results from 50 healthy elderly controls (HC), 
unambiguous and culturally neutral pictures were identified from the International 
Picture Naming Project (IPNP). Shortlisted pictures were then used to construct test 
items in the 5 cognitive domains (Nagendran et al, 20 15). A VCA T scale range of 
0-30 was preplanned with lower scores indicating greater cognitive impairment 
A cut-off of 18-22 suggests cognitive impairment, whereas scores of0-17 indicates 
the likelihood of a patient having dementia. In a validation study by Nagendran et al 
in 2015, the diagnostic performance ofVCAT was generally satisfactory and similar 
to MoCA and MMSE in the detection ofMCI and Alzheimer's. 
As the VCA T is a visual based test. it is not suitable for patients with visual 
impairment. It may also not be suitable for use in patients suspected to have moderate 
to severe dementia, as well as patients with dementia presenting with isolated 
language impairment (Nagendran et al, 2015). 
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CHAPTER3:METHODOLOGY 
3.1 Research Objectives 
To establish the use ofVCAT for the detection of mild cognitive impairment (MCI) in a 
multi-racial literate urban area of the University of Malaya Medical Center (UMMC). 
3.2 Research Hypotheses 
Hypothesis 1: The VCAT, which is a cognitive evaluation test based on pictures, 
images and figures will be more practical in multilingual populations as it removes 
the need for translations with consequent loss of the original intent of tests. 
Hypothesis 2: The VCAT will have sensitivity and specificity comparable to the 
MoCA for the detection of mild cognitive impairment. Compared to the MoCA. 
the VCA T can be administered without the need for translation and >90% of subjects 
will be able to complete the test. 
3.3 Research design and Sample Population 
This is a cross-sectional study that looks at the efficacy of VCAT in screening and 
detecting early dementia in the elderly. Patients were recruited from the Falls clinic 
of UMMC from December 2016 until September 2017. Ethical approval was obtained 
from the UMMC Medical Ethics Committee. 
3.4 Inclusion criteria 
-Age ~0 years 
-Seen at the Falls Clinic, UMMC 
-Able to complete the MMSE, MoCA and VCA T tests 
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3.5 Exclusion Criteria 
- Presence of serious systemic, neurologic or psychiatric disease 
- Patients with poor vision, who in the judgement of the clinician is unable perform 
VCAT 
3.6 Definition of Mild Cognitive Impairment and Dementia 
Mild cognitive impairment and dementia were diagnosed using two established 
criteria. The diagnosis of the MCI was made based on the Petersen's!NlA-AA criteria, 
while mild to moderate dementia was determined using the NINDS-ADRDNNIA-AA 
criteria. In addition, individuals with a clinical dementia rating (CDR) total score of 
0.5 were considered MCJ patients and those with a CDR of 1.0-2.0 were considered 
mild to moderate dementia. 
3. 7 Data Collection 
Data was collected from consenting patients who fulfilled the inclusion criteria. 
Participants who agreed to participate with cognitive assessment and evaluation were 
asked to sign the consent form prior the evaluation. The MMSE, MoCA and VCA T 
were administered consistently in the stated order. In addition, participants' physical 
attributes, education level, past medical history and medication history. Participants 
were also asked to appraise overall and domain-level cognitive load of the VCAT. The 
appraisal covered comprehensibility of items, perceived difficulty level and overall test 
length. 
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3.8 Data Processing and Analysis 
The Statistical Package for Social Sciences (SPSS for Mac version 23) was used for 
all statistical analyses. Data on patients' characteristics and demographics were 
presented as mean and standard deviation. Categorical data were presented as 
numbers with percentages. 
The validity of VCA T in comparison to MMSE and MOCA was evaluated using 
Pearson's rank order correlation coefficient. Diagnostic performance was assessed using 
area under the curve (AUC), sensitivity, specificity, and positive and negative predictive 
values. The precision of estimates is given by 95% confidence intervals. 
One way Analysis of Variance (ANOVA) was used to compare means between the 
cognitive tests, physical parameters as well as patients' characteristics. Post-hoc 
analysis using LSD was also done for the VCAT, MoCA and MMSE. 
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CHAPTER 4: RESULTS 
4.1 Baseline Demographics 
A total of 116 patients were recruited for this study. Out of this number, only data 
from 96 patients were included, as 4 recruits withdrew and another t 6 did not 
complete one or more of the memory tests. 
Table I shows demographic data for study population. The group was divided into 
50 Healthy Fallers (HF) and 46 Cognitively Impaired Subjects (CIS), 
out of which 36 were diagnosed to have dementia, and the remaining 10 had MCI. 
The majority were female (53%), mean age 76.12 ± 7.72, ranging from 56-91 years 
of age. 65% were ethnic Chinese, 18% Indian, 9% Malay, 3% Sikh, and I% others. 
The groups ofNC and CIS were similar in racial composition as well as in the 
number of patients whose primary language was English. An analysis of variance 
(ANOV A) showed that increasing age and low education levels increase the risk of 
dementia, with p<0.002 for both categories respectively. 
Table 1: Patients demographics characteristics 
Attributes HF MCI Dementia p value 
N=50 N=IO N=36 
Mean age (SD) 73.6(8.02) 76.1(7.92) 79.6(5.92) 0.002* 
Gender(percentages) 
Female 27(54) 2(20) 24(66) 0.03 1 
Male 23(46) 8(80) 12(33) 
BMI , mean (SD) 24.4(3.59) 23.5(3.46) 24.02(3.99) 0.741 
Mean years of II (4) 13(2) 8(5) 0.002* 
education(SD) 
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Ethnicity 
Chinese 32(64) 6(12) 27(75) 0.310 
Indian 11(22) 3(30) 4(11) 
Malay 6(12) 1 (1 0) 2(6) 
Sikh 0 0 
~ 
3(8) 
Others 1(2) 0 0 
Participants primary 
language 
English 34(68) 9(90) 24(67) 0.644 
Mandarin 5(10) 0 4(8) 
Cantonese 4(8) 1(1 0) 5(14) 
Malay 7(14) 0 3(8) 
. . . . MCI, mild cogmtJVe 1mpamnent: BMI, Body Mass Index; SD. Standard Dev1at1on 
HF. Healthy Fallers 
4.2: Outcomes ofVCAT, MoCA and MMSE 
Diagnostic performance of the VCAT was similar to MoCA and MMSE m 
differentiating between MCI and dementia (Table 2). To discriminate between HF 
and CIS (MCI+Dementia), the area under the curves (AUCs) (95% Confidence 
Intervals) arc as follows: 
YCAT (cut-off=22) (Nagendran et al 2015) 88.3(81.3 to 95.3), MoCA (cut-off 26) 
(Nasreddinne et al 2005) 91.6 (86 to 97.2), and MMSE (cut-off 27) 89.5% (83.4 to 
95.6) (Kukull et al 1994) (Figure I). 
YCAT had a sensitivity of80% and specificity of 82%. The negative predictjve 
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value was 87.7% and the positive predictive value was 77.1 %. The results were 
comparable to MMSE (Se=73.3%, Sp=86%), MoCA (Se=91.1 %, Sp=60%). 
The Pearson correlations with MoCA and MMSE were 0.797 and 0.667 
respectively, demonstrating concurrent validity of VCAT with MoCA and MMSE 
(Table 3). 
Table 2: VCAT, MoCA, MMSE total scores 
Test HF, mean MCI, mean (SD) Dementia, P value MCI vs 
(SD) N=IO mean(SD) dementia 
N=50 N=36 
VCAT 24(4.0) 20(4.0) 14(16) <0.001 * 
MoCA 26(3.0) 24(3) 16(5.0) <0.001 * 
MMSE 28(1.0) 26(2) 21(6) <0.001 * 
.. HF, Healthy Fallers: MCI. Mild Cogn1t1ve lmpamnent 
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Figure 1: Receiver operating characteristic curves (MMSE, Mini-Mental State 
Examination, MoCA, Montreal Cognitive Assessement) 
ROC Curve 1 o,.,-_____ _ 
01 
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1 - Specificity 
Sourct of tht 
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- ... u• 
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VCAT AUC=<88.3%(81.3.95.3),MoCA AUC 91.6%(86.0.97.2). MMSEAUC 89.5%(83.4,95.6) 
Cut-off scores to determine CIS: 
VCAT (cut-off=22): (Nagendran et al2015) 
MoCA (cut-off26): (Nasreddinne et al2005) 
MMSE (cut-off27): (Kukull et al 1994) 
Table 3: Pearson correlations between VCAT, MoCA and MMSE 
MMSE VCAT MoCA 
VCAT Pearson 0.667 1 0.797 
Correlation 
Sig.(2-tailed) <.001 * <.001 * 
N 96 96 96 
The distribution scores for VCAT, MoCA and MMSE are shown in figures 2a, 2b, 
and 2c respectively. The results show a ceiling effect for MMSE and MoCA, but 
not for VCAT. 
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Figure 2a: Histogram ofVCA T score range for Study Population 
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Figure 2b: Histogram ofMoCA score range for Study Population 
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Figure 2c: Histogram of MMSE score range for Study Population 
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The VCAT, MMSE and MoCA results also demonstrated a positive correlation 
with right and left grip strength. There is, however, no correlation between 
Time Up and Go (TUG), as well as Functional Reach (FR) with all three memory 
tests (Table 4). The mean time to complete the VCAT was around 13 minutes 
(SD=5.68). and is comparable to the times taken to complete the MMSE (5-1 Ominutes-
Tambaugh and Mcintyre, 1992), as well as the MoCA (I 0 minutes- Nasreddinne et al, 
2005). 
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Table4: Pearson's Correlation of physical parameters with VCAT, MoCA 
andMMSE 
Mean(SD) HF MCI Demented p value 
Time up and Go 16( 11) 21(13) 20(13) 0.284 
(seconds) 
Functional 17(13) 13(13) 1 0(13) 0.050 
reach (em) 
Right hand grip 17( 11) 15(12) 1 0(1 0) 0.011 * 
Left hand grip 16(11) 11(9) 9(9) 0.005* 
Post-hoc analysis using LSD on all 3 cognitive tests shows that MMSE and 
MoCA significantly differentiated MCI from dementia (MMSE, p<O.OOI and 
MoCA, p<O.OO 1 ); as well as differentiating healthy fallers (HF) from dementia (MMSE, 
p<0.001 and MoCA, p<O.OOl). 
However, there was no significant difference between HF and MCJ in terms of 
MMSE (p=O.l38) or MoCA (p=0.318). 
The VCAT, however, correctly differentiated between HF and MCI (p=0.036), 
MCI and dementia (p=0.002), and HF and dementia (p<O.OOl). All 3 cognitive 
tests showed similar association between grip strengths, FR and TUG; this also 
adds to the validity ofVCAT as a cognitive assessment tool. 
As documented in Table 4, only grip strength showed a positive correlation with 
dementia. 
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CHAPTER 4: DISCUSSION 
4.1. Interpretation and findings 
The VCA T was initially developed as a novel visual based screening test designed to 
detect dementia at an early stage. As it is visual based, it does not need to be 
translated or adapted to other languages (Nagendran et at, 2015). It can also be 
administered in any language as long as the test administrator and the participant 
converse in the same language (Nagendran et al 2015). 
In this study, the VCAT demonstrated comparable diagnostic performance as the 
MoCA and MMSE in terms of specificity and sensitivity. The VCA T shows better 
sensitivity than MMSE (80%), and better specificity compared to MoCA (82%). 
In addition, VCAT offers better differentiation in post-hoc analysis for HF versus 
MCI as compared to MoCA and MMSE. In distinguishing between MCI, dementia, 
and healthy fallers, there was no ceiling effect seen in distribution of scores for 
VCA T when compared to MoCA and MMSE. This may make VCA T a more useful 
tool for the detection ofMCI in the elderly. 
In comparing between the frailty measures (time up and go, functional reach, grip 
strength) among the participants, only grip strength was shown to have a positive 
correlation with dementia. This finding was also reported by Rogers et al in 2008, which 
suggested that dementia is associated with strength loss, a key contributor to 
functional disability. Idiopathic decline in motor function is a familiar consequence 
of aging, with older persons displaying a wide spectrum of loss of muscle strength, 
muscle bulk, and walking speed (Camicioli R. et al 2007). These deficits are subsumed 
under several constructs, including physical frailty, sarcopenia, and parkinsonism, 
and there is now considerable evidence showing that idiopathic decline in motor 
function is common in old age and precedes and predicts a wide range of important 
health and cognitive outcomes, including death, disability, MCI, and dementia 
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(Mitchell et a1 2006, Wang Let al 2006, Waite LM et al 2005). The TUG in this 
study did not show a positive correlation as there may be a large variability due to 
factors as mentioned above (physical frailty, sarcopenia, parkinsonism). 
There was a positive correlation between advancing age and education levels with 
dementia. Jorrn A.F et al in 2007 found that the relationship between prevalence and 
age was remarkably consistent, with estimated prevalence rates doubling every 5.1 
years, up to the age of95 years. The 95% confidence interval for this doubling period 
is 4.8-5.4 years. Persons with higher educational attainment may have a greater 
cognitive reserve that can postpone the clinical manifestation of dementia. 
Unhealthy lifestyles may independently contribute to the depletion of this reserve or 
directly influence the underlying pathologic processes (Ngandu T et al 2007). 
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4.2. Strengths and limitations 
The initial validation study had a sample of206 participants. This study had a 
relatively smaller number of samples, which was 96 participants. However, the 
results of this study are identical in terms of comparative findings with MoCA and 
MMSE. The number of participants detected to have MCI was only 10, compared to 
dementia which was 36. This could be due to the fact that the NNIA criteria may 
have led to some patients being classified as dementia instead ofMCI. 
There may be some element of fatigue among the participants when they were tested 
with all 3 congnitive tests in succession. One of the ways to avoid this is for the patients 
to be tested with the cognitive tests on separate days in a given week. The drawback is 
that some patients may have logistic difficulties in coming frequently within a short 
span of time. If the cognitive tests were done separately over a longer duration of time, 
it may not be accurate also as their cognition may change within that period of time. 
The functional impairment in the dementia group may be due to other factors rather 
than dementia. This may be addressed by a study using continuous cognitive scores 
adjusted for the presence of other conditions. A larger sample is required for such a 
study, which is outside the scope of this current study. 
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4.3. Summary and recommendations 
The VCA T is comparable to MoCA and MMSE as a cognitive assessment tool. 
Being a visual based test, it does not need to be translated into other languages, 
thus making it more feasible for use in a multiculturaJ society. 
The VCA T may need some minimal training initially for those who have not conducted 
the test before. It is simple enough to be administered by either a clinician or an 
occupational therapist. The VCAT can be used on its own, or with other cognitive tests 
as a screening tool for MCI or dementia in either the outpatient or hospital setting. 
Patients whose caregivers, or they themselves report memory impairment should be 
deemed suitable to undergo cognitive assessment tests such as the VCAT, and that their 
progress should be documented during subsequent clinic sessions. 
It is recommended to have larger samples for future studies to better understand the 
psychometric properties of other criteria for the diagnosis of dementia. In terms of 
clinical practice, VCAT may be better than MMSE and MoCA in detecting MCI and 
dementia, especially when it is being used in a multilingual and multicultural 
population. 
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Visual Cognitive Assessment Test (VCAT) 
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MoCAForm: 
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Clinical Dementia Rating (CDR) Form: 
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